An insight into the hepatocellular death induced by amphetamines, individually and in combination: the involvement of necrosis and apoptosis

Abstract

The liver is a vulnerable target for amphetamine toxicity, but the mechanisms involved in the drug's hepatotoxicity remain poorly understood. The purpose of the current research was to characterize the mode of death elicited by four amphetamines and to evaluate whether their combination triggered similar mechanisms in immortalized human HepG2 cells. The obtained data revealed a time- and temperature-dependent mortality of HepG2 cells exposed to 3,4-methylenedioxymethamphetamine (MDMA, ecstasy; 1.3 mM), methamphetamine (3 mM), 4-methylthioamphetamine (0.5 mM) and D-amphetamine (1.7 mM), alone or combined (1.6 mM mixture). At physiological temperature (37 °C), 24-h exposures caused HepG2 death preferentially by apoptosis, while a rise to 40.5 °C favoured necrosis. ATP levels remained unaltered when the drugs where tested at normothermia, but incubation at 40.5 °C provoked marked ATP depletion for all treatments. Further investigations on the apoptotic mechanisms triggered by the drugs (alone or combined) showed a decline in BCL-2 and BCL- XL mRNA levels, with concurrent upregulation of BAX, BIM, PUMA and BID genes. Elevation of Bax, cleaved Bid, Puma, Bak and Bim protein levels was also seen. To the best of our knowledge, Puma, Bim and Bak have never been linked with the toxicity induced by amphetamines. Time-dependent caspase-3/-7 activation, but not mitochondrial membrane potential (∆ψm) disruption, also mediated amphetamine-induced apoptosis. The cell dismantling was confirmed by poly(ADP-ribose)polymerase proteolysis. Overall, for all evaluated parameters, no relevant differences were detected between individual amphetamines and the mixture (all tested at equieffective cytotoxic concentrations), suggesting that the mode of action of the amphetamines in combination does not deviate from the mode of action of the drugs individually, when eliciting HepG2 cell death.

Drugs of abuse and addiction: A slippery slope toward liver injury

“…Time-dependent caspase-3/-7 activation, but not mitochondrial membrane potential (∆ψm) disruption, also mediated amphetamine-induced apoptosis. Overall, for all evaluated parameters no relevant differences were detected between individual amphetamines and the combination (all tested at equi-effective cytotoxic concentrations), suggesting that the mode of action of the amphetamines in combination does not deviate from the mode of action of the drugs individually when eliciting HepG2 cell death [46]. In another set of…”

The Role of Adverse Event Reporting in the FDA Response to a Multistate Outbreak of Liver Disease Associated with a Dietary Supplement

“…However, the physiologic actions of DMAA on the body are similar to amphetamine and ephedrine, 15 and, notably, the liver is vulnerable to amphetamine toxicity. 16 As for aegeline, feeding trials in rats with Aegle marmelos, a plant with a long history of use in Ayurvedic medicine, produced hepatic lesions that included central vein abnormalities. 17 Illness outbreaks, regardless of etiology, pose challenges in many forms.…”

In vitro hepatotoxicity of ‘Legal X’: the combination of 1-benzylpiperazine (BZP) and 1-(m-trifluoromethylphenyl)piperazine (TFMPP) triggers oxidative stress, mitochondrial impairment and apoptosis

“…In either case, excessive apoptotic activation might lead to serious complications (e.g., autoimmune deregulation, neurodegenerative diseases, cancer, etc.). It is also possible that piperazine designer drugs preferentially die by apoptosis (Arbo et al 2016), but necrotic pathways activation under more stressful cell conditions should not be excluded (Dias da Silva et al 2014a;Dias da Silva et al 2013a).…”